Sep 2026
Repurposing Gastric Cancer Biomarkers for Mucinous Ovarian Carcinoma: ERBB2 and Claudin 18.2 as Therapeutic Targets.
While the immunohistochemical panel developed is of insufficient diagnostic accuracy to distinguish MOC from GA, consideration should be given to include MOC in clinical basket trials targeting ERBB2 and Claudin 18.2.
Shuai Wang, A. de Boeck, E. Kang et al.
· International Journal of Gyn... · 0 citations